Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Comparison of US-guided TROcar Versus SELdiger Technique for Percutaneous Cholecystostomy. The TROSELC II Trial.

NCT04602156 is registered in ClinicalTrials.gov with Attikon Hospital as lead sponsor.

NCT NCT04602156
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04602156 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Comparison of US-guided TROcar Versus SELdiger Technique for Percutaneous Cholecystostomy. The TROSELC II Trial.
Lead sponsor
Attikon Hospital
Phase
Not applicable
Overall status
Completed
Start date
September 16, 2020
Completion date
November 22, 2022
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cholecystitis